Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.760
-0.035 (-4.38%)
At close: Dec 26, 2024, 4:00 PM
0.789
+0.029 (3.82%)
After-hours: Dec 26, 2024, 7:59 PM EST
Hoth Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Hoth Therapeutics stock have an average target of 4.75, with a low estimate of 3.00 and a high estimate of 7.00. The average target predicts an increase of 525.00% from the current stock price of 0.76.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 13, 2024.
Analyst Ratings
The average analyst rating for HOTH stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +557.89% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +426.32% | Nov 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +426.32% | Oct 16, 2024 |
| Benchmark | Benchmark | Buy Reiterates $3 | Buy | Reiterates | $3 | +294.74% | Oct 11, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +557.89% | Sep 5, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.30
from -2.30
EPS Next Year
-0.72
from -1.30
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.24 | -0.58 | -0.65 |
| Avg | -1.30 | -0.72 | -0.63 |
| Low | -1.33 | -0.85 | -0.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.